Crystal structure of bisoprolol fumarate Form I, (C18H32NO4) (C4H2O4)0.5

被引:1
|
作者
Kaduk, James A. [1 ,2 ]
Gindhart, Amy M. [3 ]
Blanton, Thomas N. [3 ]
机构
[1] IIT, 3101 S Dearborn St, Chicago, IL 60616 USA
[2] North Cent Coll, 131 S Loomis St, Naperville, IL 60540 USA
[3] ICDD, 12 Campus Blvd, Newtown Sq, PA 19073 USA
关键词
bisoprolol fumarate; Zebeta; powder diffraction; Rietveld refinement; density functional theory; DIFFRACTION; VALIDATION; PATTERNS; DENSITY;
D O I
10.1017/S0885715619000757
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The crystal structure of bisoprolol fumarate Form I has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional techniques. Bisoprolol fumarate Form I crystallizes in space group P-1 (#2) with a = 8.165 70(5) angstrom, b = 8.516 39(12) angstrom, c = 16.751 79(18) angstrom, alpha = 89.142(1)degrees, beta = 78.155(1)degrees, gamma = 81.763(1)degrees, V = 1128.265(10) angstrom(3), and Z = 2. The neutral side chain of the bisoprolol cation is probably disordered. The cation and anion are linked by N-H center dot center dot center dot O and O-H center dot center dot center dot O hydrogen bonds. The cations are also linked by N-H center dot center dot center dot O hydrogen bonds. The result is alternating layers of hydrophilic and hydrophobic layers parallel to the ab-plane. The density of the structure is relatively low at 1.130 g cm(-3), but there are no obvious voids in the structure. The powder pattern is included in the Powder Diffraction File (TM) as entry 00-066-1625. (C) 2019 International Centre for Diffraction Data.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 50 条
  • [31] Crystal structure of hyoscyamine sulfate monohydrate, (C17H24NO3)2(SO4)(H2O)
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2020, 35 (04) : 286 - 292
  • [32] Crystal structure of oxybutynin hydrochloride hemihydrate, C22H32NO3Cl(H2O)0.5
    Kaduk, James A.
    Boaz, Nicholas C.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (01) : 50 - 58
  • [33] Crystal structure of paliperidone palmitate (INVEGA SUSTENNA®), C39H57FN4O4
    Kaduk, James A.
    Dmitrienko, Artem O.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2017, 32 (04) : 222 - 227
  • [34] Crystal structure of vardenafil hydrochloride trihydrate, C23H33N6O4SCI (H2O)3
    Wheatley, Austin M.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2018, 33 (04) : 319 - 326
  • [35] Crystal structure of edoxaban tosylate monohydrate Form I, (C24H31ClN7O4S) (C7H7O3S)(H2O)
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2021, 36 (02) : 107 - 113
  • [36] Crystal structure of valbenazine, C24H38N2O4
    Ens, Tawnee M.
    Kaduk, James A.
    Rost, Megan M.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, 39 (03) : 176 - 181
  • [37] Crystal structure of nequinate, C22H23NO4
    Kaduk, James A.
    Gindhart, Amy M.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (04) : 211 - 215
  • [38] Crystal structure of cephalexin monohydrate, C16H17N3O4S(H2O)
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2020, 35 (04) : 293 - 300
  • [39] Crystal structure of brimonidine hydrogen tartrate, (C11H11BrN5)(HC4H4O6)
    Kaduk, James A.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, 39 (03) : 144 - 150
  • [40] Crystal structure of (Z)-cefprozil monohydrate, C18H19N3O5S(H2O)
    Butler, Zachary R.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (04) : 379 - 388